Průcha M.1, Zazula R.2, Dubská L.1, Sedláčková L.1, Kavka B.3:
Průcha M., Zazula R., Dubská L., Sedláčková L., Kavka B.: Pro-atrial natriuretic peptide in patients with sepsis,
severe sepsis and septic shock
|
127 |
Zdráhal Z., Fajkus J.:
Mass spectrometry and proteomics
|
132 |
Štern P., Trnková B., Šebesta I., Zima T.:
Studies at Medical Schools in 13 countries of EU and teaching of
biochemistry and clinical biochemistry
|
138 |
Birková A., Dubayová K., Kušnír J.:
Metabolic profiling – the novel look at the valuation of biological material
|
145 |
Chrastina P., Martincová O., Berná L., Ledvinová J.:
Tandem mass spectrometry of globotriaosylceramide:
quantification in plasma and urine for diagnosis and therapy
monitoring in Fabry disease
|
150 |
Klapková E.1, Průša R.1, Kukačka J.1, Kotaška K.1, Škapa P.2:
Unexpected high serum level of CA 125 in male patient
suffering from metastatic papillary carcinoma: a case report
|
155 |
Kukačka J., Klapková E., Průša R.:
Presumptive combinatory HPLC determination of fetal hemoglobin employing
mode for glycated hemoglobin
|
157 |
Cibulka R.1, Rajdl D.1, Široká R.1, Eiselt J.2, Malánová L.3, Trefil L.1, Racek J.1:
Asymmetric dimethylarginine (ADMA) as
a novel prognostic factor for survival in hemodialysis patients
|
160 |
Friedecký B.:
Serum creatinine and estimation of glomerular filtration rate
|
164 |
Pikner R.1, Lavička P.2, Kormunda S.3, Topolčan O.4, Bosman R.5, Chytra I.5, Holubec L.4, Choc M.2:
Verifying of S100B and
NSE reference interval – age, gender and sampling time dependence
|
168 |
Friedecký B.:
Reference materials and in vitro diagnosis
|
174 |
